On the issue of exercise normalcy by Neder, Jose Alberto
5 Smyth LJC, Starkey C, Vestbo J, et al. CD4-regulatory cells in
COPD patients. Chest 2007; 132: 156–163.
6 Plumb J, Smyth LJC, Adams HR, et al. Increased T-regulatory cells
within lymphocyte follicles in moderate COPD. Eur Respir J 2009;
34: 89–94.
7 Barcelo B, Pons J, Ferrer JM, et al. Phenotypic characterisation of
T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory
T-lymphocyte response to tobacco smoking. Eur Respir J 2008; 31:
585–562.
8 Lee SH, Goswami S, Grudo A, et al. Antielastin autoimmunity in
tobacco smoking-induced emphysema. Nat Med 2007; 13: 567–569.
9 BTS guidelines for the management of chronic obstructive pulmon-
ary disease. The COPD Guidelines Group of the Standards of Care
Committee of the BTS. Thorax 1997; 52: Suppl. 5, S1–S28.
10 Pauwels RA, Buist AS, Calverey MA, et al. Global strategy for the
diagnosis, management, and prevention of chronic obstructive
pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1256–1276.
11 Saetta M, Turato G, Maestrelli P, et al. Cellular and structural bases
of chronic obstructive pulmonary disease. Am J Respir Crit Care
Med 2002; 163: 1304–1309.
DOI: 10.1183/09031936.00047009
On the issue of exercise normalcy
To the Editors:
Cardiopulmonary exercise testing (CPET) has evolved as a
useful tool for evaluation of exercise capacity in apparently
healthy subjects. In the clinical arena, CPET is widely used to
judge exercise ‘‘normalcy’’ in individuals with a suspected
disorder and patients with several potential causes of exercise
limitation [1]. In order to establish ‘‘abnormality’’, however, it
is crucial to obtain representative frames of reference to
interpret the (lack of) appropriateness of the systemic
responses to exertion. Unfortunately, this is not a trivial task
in the nonathletic subject as there are multiple confounding
factors, especially behavioural characteristics such as the level
of regular physical activity. Not surprisingly, there are only a
few sets of reference values for clinical CPET interpretation
which have survived the proof of time and are currently used
worldwide [1].
In this context, the study recently published in the European
Respiratory Journal by KOCH et al. [2] is welcomed. After
evaluating a large sample of apparently healthy males and
females with a wide range of age and body dimensions, KOCH
et al. [2] provided a comprehensive set of prediction equations
for the main CPET variables. The authors carefully avoided
some well-known confounding factors, especially those related
to past or current medical conditions, and the statistical
analysis was unusually sophisticated.
There is, however, one major shortcoming in the study by
KOCH et al. [2] which might hamper its application in clinical
practice. Unfortunately, the participants were not randomly
selected from the general population, i.e. they freely volun-
teered to the study as part of a larger investigation on health-
related outcomes in Germany. Consequently, it is conceivable
that the more active subjects participated, an effect that is likely
to be more relevant for the older groups. In fact, the authors
stated that ‘‘the influence of physical activity was not
consistently significant throughout the investigated groups’’
[2], which suggests that the elderly group were as active as the
younger subjects. The hypothesis that the study has been
biased to evaluate subjects who were more active than the
sedentary, general population is consistent with the higher
prevalence of nonsmoking and nonhypertensive subjects in the
group of volunteers compared with the complete population
(p,0.05). Moreover, the age-related decline in peak oxygen
uptake (V9O2) was lower than previously reported by most of
the previous studies and the predicted values for subjects aged
.40 yrs were systematically higher than estimated by other
commonly used equations. Therefore, age-related decline in
predicted V9O2 from age 20–25 to 65 yrs has been previously
estimated to average 20–25% in sedentary subjects; in contrast,
KOCH et al. [2] reported only a 15% decrease in males and
females. As a consequence, figure 5 from the study by KOCH et
al. [2] shows that the median peak V9O2 values predicted by
three other equations for subjects aged o65 yrs were in the
lower quartiles or close to the 5th percentile in males and
females, respectively. Collectively, these findings seem to
indicate that the reference values of KOCH et al. [2] are of
limited value for the evaluation of exercise normalcy in the
specific sub-population of sedentary elderly subjects in whom
cardiopulmonary diseases are more prevalent [3] and CPET
could be clinically more useful.
We have previously reported the findings of a similar, albeit
smaller, study in which the subjects were randomly selected
from a database of .8,000 subjects [4]. Although this study
feature increased enormously the complexity of the investiga-
tion, it eventually proved essential to obtain truly representa-
tive data for clinical interpretation of CPET. For instance,
occasional volunteers were submitted to the same evaluation
protocol but results were not considered on the final analysis.
As expected, they were more active, fitter and leaner than the
randomised subjects. In fact, if data from the nonrandomised
subjects had been included in the analysis, predicted peak V9O2
values would be almost 20% higher, i.e. values quite similar to
those reported by Koch et al. [2]. In our view, this is the main
reason that explains why our prediction equations provide the
lowest peak V9O2 values amongst other sources of reference
values, e.g. fig. 5 from KOCH et al. [2]. Moreover, we developed
reference values for several effort-independent, submaximal
relationships obtained in the incremental phase of exercise [5].
Considering that these variables are less influenced by
maximal aerobic capacity, KOCH et al. [2] might have excellent
material in their hands to further contribute to the field.
In conclusion, it is our opinion that the ‘‘ideal’’ set of reference
values for clinical interpretation of CPET is still to be
generated. Although such investigation would certainly share
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many of the characteristics of the study by KOCH et al. [2], the
issue of subject randomisation will be critical to improve our
confidence on the limits of normality for key CPET variables.
J.A. Neder
Respiratory Division, Dept of Medicine, Paulista School of
Medicine, Federal University of Sa˜o Paulo, Sa˜o Paulo, Brazil.
Correspondence: Federal University of Sa˜o Paulo, Pulmonary
Function and Clinical Exercise Unit, R. Prof Francisco de
Castro 54, Sa˜o Paulo, 04050-032, Brazil. E-mail: albneder@
pneumo.epm.br
Statement of Interest: None declared.
REFERENCES
1 ERS Task Force, Palange P, Ward SA, et al. Recommendations on the
use of exercise testing in clinical practice. Eur Respir J 2007; 29: 185–
209.
2 Koch B, Scha¨per C, Ittermann T, et al. Reference values for
cardiopulmonary exercise testing in healthy volunteers: the SHIP
study. Eur Respir J 2009; 33: 389–397.
3 Stewart KJ. Physical activity and aging. Ann N Y Acad Sci 2005; 1055:
193–206.
4 Neder JA, Nery LE, Castelo A, et al. Prediction of metabolic and
cardiopulmonary responses to maximum cycle ergometry: a
randomised study. Eur Respir J 1999; 14: 1304–1313.
5 Neder JA, Nery LE, Peres C, Whipp BJ. Reference values for dynamic
responses to incremental cycle ergometry in males and females aged
20 to 80. Am J Respir Crit Care Med 2001; 164: 1481–1486.
DOI: 10.1183/09031936.00030809
From the authors:
Based on results of their important studies and assumptions
concerning the Study of Health in Pomerania (SHIP) database,
J.A. Neder questions the relevance of our report on reference
values for cardiopulmonary exercise testing (CPET) [1]. The
establishment of close-to-reality reference values for the
clinical interpretation of CPET is indeed an important issue
since a consensus has not yet been reached on the definition of
normalcy. Therefore, we consider our study to be an additional
contribution to present an ‘‘ideal’’ set of normative values for
CPET. In this context, the major strength of the current study
first lies in the use of data from a large population-based
sample of adults. Secondly, the consideration of echocardio-
graphical and lung functional data besides comprehensive
information on past and current medical history, as well as the
performance of all kinds of clinical examination methods
contributes exceedingly to the establishment of a disease-free
reference sample.
J.A. Neder mainly criticises the issue of voluntary participation
and the aspect of too little consideration of physical activity in
the current study sample on CPET. At this point, we would
like to put emphasis on the fact that the SHIP study sample
itself, including the participants in CPET, was randomly
selected from the general population via registration offices
[2]. Within a democratically ruled country, eventual participa-
tion in the study is dependent on voluntary participation.
Therefore, one can argue that every epidemiological survey, to
some extent, is biased, as stated in the published article; a
selection bias towards younger and healthier individuals was
evident. However, by means of adjusting for age and applying
stringent exclusion criteria towards healthy participants, this
should only marginally affect the normative limits for CPET.
J.A. Neder impeaches the applicability of the present reference
values in the specific sub-population of sedentary elderly
subjects since the described predicted values for peak oxygen
uptake (V9O2) were systematically higher than those previously
described. Besides a selection bias towards younger and
slimmer volunteers our data may be biased by analysing
CPET results of physically more active participants aged
o50 yrs (,2 h?week-1 versus o2 h?week-1; p,0.01). Within the
group of participants in CPET (n5534 versus n51,174) no
significant difference in the levels of physical activity was
found (p50.241). So far, we agree with J.A. Neder. However, in
our view the effect of excluding participants with coexisting
and as yet unknown diseases has been shown to have an even
more important impact in this subpopulation. Due to results
derived within the examination process, 74% of the subjects
aged .50 yrs had to be excluded. This clearly shows the
importance of a wide spectrum of examination methods beside
patients self report to detect and consequently exclude
coexisting pathologies. NEDER et al. [3] tried hard to establish
a disease free study sample, but alike comparable studies to
some extent all cardiorespiratory disorders might not have
been detected in advance. Furthermore, the majority of studies
concerning reference values might be criticised for not being
population based and, thus, of limited comparability to our
study design. Besides less accurately assessed exclusion
criteria, another major shortcoming of other previous studies
seems to be the inclusion of individuals who smoke even
though an impact of cigarette smoking on exercise capacity
assessed by peak V9O2 and V9O2 at anaerobic threshold has
been shown [4, 5].
One can easily argue that every existing study on reference
values for CPET shows limitations. Nevertheless, every piece
of work on this issue seems to contribute to close-to-reality
normative values. It is incontrovertible that the present
findings are the first considering such an amount of different
medical examination methods for the establishment of a
healthy study sample across a wide age range. However,
everybody working on reference values for CPET should be
encouraged to do so, since, and at this point we completely
agree with J.A. Neder, the ‘‘ideal’’ set of reference values for
CPET might still to be generated.
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